文献速递胃肠外科围术期管理与 ERAS

术后阿片类药物介导的加速康复机器人结肠切除术后肠梗阻危险因素

Risk factors for ileus after enhanced recovery robotic colectomy mediated by postoperative opioids: a single institution analysis.
PubMed 文献 · Surg Endosc · 2025-05-02

该单中心回顾性分析纳入2018年至2024年行机器人右半或左半结肠切除术的患者,主要结局为术后肠梗阻。中介分析显示术后阿片类药物使用与肠梗阻相关(OR 2.83,CI 1.18-14.67),且是唯一可改变的危险因素。

要点

  • 术后阿片类药物使用是机器人结肠切除术后肠梗阻的唯一可改变危险因素。
  • 术后阿片类药物与肠梗阻相关(OR 2.83,CI 1.18-14.67)。
  • 考虑其他节约阿片类药物的加速康复路径可能减少肠梗阻。

核心结论

  • 术后阿片类药物是机器人节段性结肠切除术后肠梗阻的唯一可改变危险因素。
  • 其他与肠梗阻相关的因素在术后加用阿片类药物后风险并未增加。

研究设计与样本

  • 单中心回顾性分析,纳入2018年1月1日至2024年7月31日前瞻性维护的机构结直肠手术数据库中机器人右半和左半结肠切除术患者。
  • 共纳入394例左半结肠切除术和267例右半结肠切除术。
  • 主要结局为术后肠梗阻,采用中介分析检验患者因素与肠梗阻的关联是否由术后阿片类药物介导。

主要发现

  • 右半结肠切除术的手术诊断中肿瘤占89.5%,左半结肠切除术中憩室病占78.7%(p < 0.001)。
  • 术后中位住院时间为2.0天。
  • 肠梗阻发生于5.6%的患者。
  • 以术后阿片类药物(静脉或口服)为中介变量的分析显示,术后阿片类药物与肠梗阻相关(OR 2.83,CI 1.18-14.67)。
  • 老年患者阿片类药物需求量较低(OR 0.96,CI 0.95-0.98),但老年患者无论是否使用阿片类药物,肠梗阻风险相同(OR 1.03,CI 1.00-1.06)。

临床怎么用

  • 考虑其他节约阿片类药物的加速康复路径选项,并增加微创手术方式的采用,可能减轻术后肠梗阻这一并发症。

局限性

  • 单中心回顾性分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Postoperative ileus (POI) after colorectal surgery is associated with prolonged hospital length of stay, readmission, and higher costs of care. POI may be unpredictable and even uncomplicated enhanced recovery elective minimally invasive colorectal operations may be complicated by ileus and readmission related to ileus. Determining if there are modifiable factors associated with ileus may suggest quality improvement interventions designed to decrease ileus. The aim of this study was to identify patient characteristics associated with ileus and the relationship with postoperative opioids. METHODS: This is a single institution retrospective analysis of robotic right and left colectomy in a prospectively maintained institutional colorectal surgery database from 1/1/2018 to 7/31/2024. The primary outcome was postoperative ileus. Mediation analysis was used to examine the association of patient factors with ileus mediated by postoperative opioids. RESULTS: There were 394 left and 267 right colectomies that met inclusion criteria. Neoplasia was the operative diagnosis for 89.5% of right colectomies and diverticular disease for 78.7% of left colectomies (p < 0.001). Median postoperative hospital length of stay was 2.0 days. Ileus occurred in 5.6% of the patient population. An analysis with postoperative opioids (intravenous or oral) as mediating variable showed that postoperative opioids were associated with ileus (OR 2.83, CI 1.18-14.67). While older patients had less opioid requirements (OR 0.96, CI 0.95-0.98), the risk of ileus (OR 1.03, CI 1.00-1.06) was the same for older patients with and without opioids. A decrease in opioid prescriptions at discharge was seen over time (p < 0.001). CONCLUSION: Postoperative opioids were the only modifiable risk factor for ileus after robotic segmental colectomy. The risk of ileus for other factors associated with ileus did not increase when opioids were added postoperatively. Considering other opioid-sparing enhanced recovery pathway options and increased adoption of the minimally invasive surgical approach may lessen this vexing postoperative complication.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Sheehan E, Brockhaus KK, Huebner M, et al. Risk factors for ileus after enhanced recovery robotic colectomy mediated by postoperative opioids: a single institution analysis. Surg Endosc. 2025. PMID: 40316749. doi:10.1007/s00464-025-11752-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。